Reading time is 1 mins
From the claims have emerged that vaccines developed against the corona virus outbreak, which has infected more than 164 million people worldwide and killed more than 3 million people, have caused serious damage to young people. In the US, on 20 May the authorities have launched an investigation into the incident.
The immune Advisory Committee of the Centers for Disease Control and Prevention (CDC), one of the leading U.S. health organizations, announced in a statement that they have received complaints that it causes side effects in some adolescents and adolescents who receive the corona virus vaccine.
A special investigation into this condition should be launched, officials warned, noting that covid-19 vaccines cause inflammation (myocarditis) in the heart of some people. It was noted that this side effect was observed, especially in men, while inflammation of the heart muscles was observed.
The CDC also explained that this condition went without any problems or other side effects, and called for research to find out the cause. Meanwhile, authorities have called for investigations to be deepened to find out how many people are suffering from the problem.
SEEN IN ISRAEL SEE ALSO
A doctor who works at the Johns Hopkins Center for Health Safety “It is necessary to determine whether this inflammation (myocarditis) that occurs in the heart has anything to do with the corona virus vaccine. It’s important to look at the risk-benefit ratio of these vaccines,” he said.
The CDC did not disclose which vaccines had this condition, but said it was seen after four days in those who had vaccines using mRNA technology. In the United States of America, there are currently two health vaccines that use the mRNA technology, Moderna and Pfizer/BioNTech.
Meanwhile, the Israeli Health Ministry announced in April 2021 that a small number of people had developed heart inflammation after receiving Pfizer’s vaccine. It said the vast majority of cases in Israel were seen in people under the age of 30, and reported was the same effects in May 2021 also.
.
.
.
Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.
Physician's Resume:
Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.
Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.
In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.
Awards:
Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.
Certificates:
Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .
Professional Members:
American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.
Disclaimer:
Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.